期刊文献+

短期胰岛素泵强化治疗对初发2型糖尿病病人胰岛β细胞功能的影响 被引量:4

The effects of short-term continue subcutaneous insulin injection on β-cell excretive function in newly diagnosed type 2 diabetic patients
原文传递
导出
摘要 目的研究短期持续皮下胰岛素输注(CSII)对初发2型糖尿病病人胰岛β细胞功能的影响。方法初发2型糖尿病患者30例,予以CSII强化治疗2周,治疗前后应用口服葡萄糖耐量试验比较血糖、胰岛素、C肽、ΔI30/ΔG30及Ho-ma-IR的变化。结果CSII强化治疗后空腹及餐后血糖明显下降(P<0.01);胰岛素、C肽释放值均升高(P<0.05);ΔI30/ΔG30升高(P<0.01);Homa-IR降低(P<0.01)。结论短期CSII强化治疗可以使初发2型糖尿病患者胰岛β细胞功能明显改善。 Objective To study the effects of short - term continue subcutaneous insulin injection (CSII) on β - cell function in newly diagnosed type 2 diabetic patients. Methods Chose 30 type 2 diabetic patients who diagnosed newly were treated with glucose tolerance test and insulin excitated test before and after CSII for two weeks. The blood glucose, insulin, C - peptide, △I30/△G30 and Homa - IR were compared. Results After CSII treatment, blood glucose was sign efficiently decreased (P 〈 0.01 ) ; insulin and C -peptide release levels were increased ( P 〈 0.05) ;△I30/△G30 was increased ( P 〈 0.01 ) ; Homa - IR was decreased ( P 〈 0.01 ). Conclusion Short - term CSII treatment can obviously improve the β - cell function in newly diagnosed type 2 diabetic patients.
作者 蔡迎九
出处 《临床医学》 CAS 2007年第3期34-35,共2页 Clinical Medicine
关键词 2型糖尿病 持续皮下胰岛素输注 Β细胞功能 Type 2 diabetes mellitus Continue subcutaneous insulin injection β -cell function
  • 相关文献

参考文献4

二级参考文献37

  • 1Erol Cerasi.胰岛素生成,胰岛素分泌及2型糖尿病:问题的核心在于β细胞(英文)[J].中华内分泌代谢杂志,2005,21(3):194-198. 被引量:86
  • 2Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 3Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 4Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 5Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 6Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 7Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 8Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 9Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 10Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.

共引文献1586

同被引文献26

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部